Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

XLV vs. RAGHX: which is better?

Bottom line

XLV vs RAGHX: the short answer

XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and RAGHX (Virtus KAR Health Sciences Fund) share a meaningful slice of their top holdings — about 49% by weight.

But XLV is far broader, holding 65 positions to 24 for RAGHX, so beyond the top names it adds exposure RAGHX doesn't have.

XLV is cheaper at 0.08% vs 1.41% — a difference of $133 a year per $10,000 invested.

Over five years, XLV returned +8.1% a year vs +2.4% for RAGHX.

RAGHX has a front-end sales load of up to 5.5%; the other does not.

Updated Nov 19, 2026

XLV vs RAGHX side by side

XLVRAGHX
TypeETFMutual fund
Fund familySPDR (State Street)Virtus
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.08%1.41%
Annual cost per $10k$8$141
10-yr cost on $10k (prospectus)$103$2,148
Max front loadNone5.5%
12b-1 fee0.02%0.25%
1-yr return+14.5%+1.3%
5-yr return (annualized)+8.1%+2.4%
10-yr return (annualized)+9.8%+6.2%
Best quarter+14.5%—
Worst quarter−12.7%—
Net assets (fund)$40.6B$91.7M
Number of holdings6524
Portfolio turnover2%13%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

11 of XLV's top 25 holdings also appear in RAGHX's top 24.

Shared top holdings
HoldingXLVRAGHX
Eli Lilly & Co16.51%14.84%
AbbVie Inc7.74%5.52%
UnitedHealth Group Inc6.57%4.65%
Merck & Co Inc5.52%5.06%
Amgen Inc3.40%3.85%
Thermo Fisher Scientific Inc3.24%3.65%
Intuitive Surgical Inc2.45%3.89%
Vertex Pharmaceuticals Inc2.19%5.32%
Danaher Corp2.09%3.37%
McKesson Corp1.58%4.57%
Regeneron Pharmaceuticals Inc1.08%2.90%

Source: SEC Form N-PORT

XLV top 10

  1. Eli Lilly & Co — 16.51%
  2. Johnson & Johnson — 10.64%
  3. AbbVie Inc — 7.74%
  4. UnitedHealth Group Inc — 6.57%
  5. Merck & Co Inc — 5.52%
  6. Amgen Inc — 3.40%
  7. Thermo Fisher Scientific Inc — 3.24%
  8. Abbott Laboratories — 2.75%
  9. Gilead Sciences Inc — 2.73%
  10. Intuitive Surgical Inc — 2.45%

RAGHX top 10

  1. Eli Lilly & Company — 14.84%
  2. West Pharmaceutical Services Inc — 5.92%
  3. Abbvie Inc — 5.52%
  4. Vertex Pharmaceuticals Inc — 5.32%
  5. Merck & Company Inc — 5.06%
  6. Unitedhealth Group Inc — 4.65%
  7. Mckesson Corp — 4.57%
  8. Mettler-toledo International Inc — 3.99%
  9. Intuitive Surgical Inc — 3.89%
  10. Amgen Inc — 3.85%

FAQ

What is the difference between XLV and RAGHX?
XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and RAGHX (Virtus KAR Health Sciences Fund) share a meaningful slice of their top holdings — about 49% by weight. But XLV is far broader, holding 65 positions to 24 for RAGHX, so beyond the top names it adds exposure RAGHX doesn't have.
Which is cheaper, XLV or RAGHX?
XLV has the lower expense ratio (0.08%).
Should I own both XLV and RAGHX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.